FS50150313: Difference between revisions
From FOIwiki
Jump to navigationJump to search
Alex skene (talk | contribs) m Text replace - "DNDecision3" to "DNDecision" |
Alex skene (talk | contribs) m Text replace - "DNDecision2" to "DNDecision" |
||
| Line 10: | Line 10: | ||
|dnd_finding=Upheld | |dnd_finding=Upheld | ||
}} | }} | ||
{{ | {{DNDecision | ||
|dnd_section=FOI 17 | |dnd_section=FOI 17 | ||
|dnd_finding=Upheld | |dnd_finding=Upheld | ||
Revision as of 22:10, 15 May 2010
Decision Summary
- Case Ref: FS50150313
- Date: 11 March 2010
- Public Authority: Medicines and Healthcare Products Regulatory Agency
- Summary: The complainant sought correspondence exchanged between the public authority and The Prince of Wales (and those who represent him) concerning the regulation of homeopathic or herbal medicines. The public authority refused to disclose the majority of this information on the basis that it was exempt from disclosure on the basis of sections 37(1)(a) and 41(1) of the Act. The Commissioner has concluded that the public authority were entitled to withhold this information on the basis of section 37(1)(a) of the Act.
- View PDF of Decision Notice: [1]
- Section of Act / Finding: FOI 17 - Complaint Upheld - Find other matching decisions
- Section of Act / Finding: FOI 37 - Complaint Not upheld - Find other matching decisions
- Section of Act / Finding: FOI 40 - Complaint Partly Upheld - Find other matching decisions
